Researchers report regenerative effects of low-dose growth factors for bone defect healing

July 27, 2017, Mary Ann Liebert, Inc
Credit: Mary Ann Liebert, Inc., publishers

Researchers compared the effects of three bone growth factors to bone morphogenetic protein 2 (BMP2)—the most commonly used agent for repair of large bone defects, which is not without risks at the doses required—and showed significant bone-healing effects including the formation of new blood vessels at low doses relative to BMP2. These findings, which suggest that the osteogenic factors Nell-1, HMGB1, and CCN2 could enhance bone defect repair using biomaterials, without the need to harvest patient tissue, are reported in Tissue Engineering, Part A.

The article entitled "Nell-1, HMGB1 and CCN2 Enhance Migration and Vasculogenesis, But Not Osteogenic Differentiation Compared to BMP2" is coauthored by Shorouk Fahmy-Garcia, Marjolein van Driel, Janneke Witte-Buoma, Johannes van Leeuwen, Gerjo van Osch, and Eric Farrell, Erasmus Medical Center, Rotterdam, The Netherlends, and Heike Walled, University Hospital Würzburg, Germany. In this study, the researchers directly compared the proteins BMP2, Nell-1, CCN2, and HMGB1 for their ability to recruit endothelial to the site of repair, promote the differentiation of two types of progenitor cells ( and fetal osteoblasts) into mature cells, and induce the formation of new blood vessels.

"The magnification of our understanding of best growth factor choices for bone repair-including the optimization of dosing to prevent side effects-is adding considerably to our capacity to control outcomes in bone engineering," says Tissue Engineering Co-Editor-in-Chief Peter C. Johnson, MD, Principal, MedSurgPI, LLC and President and CEO, Scintellix, LLC, Raleigh, NC.

Explore further: Protein combination improves bone regeneration, study shows

More information: Shorouk Fahmy-Garcia et al, Nell-1, HMGB1 and CCN2 enhance migration and vasculogenesis, but not osteogenic differentiation compared to BMP2, Tissue Engineering Part A (2017). DOI: 10.1089/ten.TEA.2016.0537

Related Stories

Protein combination improves bone regeneration, study shows

January 28, 2016
A UCLA research team has found a combination of proteins that could significantly improve clinical bone restoration. The findings may be a big step toward developing effective therapeutic treatments for bone skeletal defects, ...

New strategy aims to enhance efficacy and safety of bone repair treatment

January 6, 2016
Bone morphogenetic protein-2 (BMP2) is used clinically to promote bone repair. However, the high BMP2 concentrations required to stimulate bone growth in humans may produce life-threatening adverse effects such as cervical ...

Researchers engineer 3-D hydrogels for tissue-specific cartilage repair

July 26, 2017
Unlike the one-size-fits-all, homogeneous approach to tissue engineering for cartilage replacement, a new study reports the ability to encapsulate cartilage-forming chondrocytes and mesenchymal stem cells in 3D hydrogels ...

New study compares bone-inducing properties of 3-D-printed mineralized scaffolds

February 13, 2017
A new study of bone formation from stem cells seeded on 3D-printed bioactive scaffolds combined with different mineral additives showed that some of the scaffold mineral composites induced bone-forming activity better than ...

3-D-printed bioabsorbable scaffold for ACL reconstruction with bone regeneration

February 27, 2017
Researchers have designed a 3D-printed porous scaffold for use in reconstructing ruptured anterior cruciate ligaments (ACL) in the knee and engineered it to deliver a human bone-promoting protein over an extended period of ...

New gene therapy for pseudarthrosis trialed at Kazan University

December 5, 2016
A team headed by Professor Albert Rizvanov, director of the Gene and Cell Technologies Open Lab, has created a gene therapy drug that encodes growth factors for the stimulation of blood vessel and bone formation. The combination ...

Recommended for you

Gut hormone increases response to food

December 12, 2018
The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist. One factor in this hunger response is a hormone found in the stomach that makes us more vulnerable to tasty ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

New mouse model may speed identification of promising muscular dystrophy therapies

December 12, 2018
A Massachusetts General Hospital (MGH) research team has created a new mouse model of a common form of muscular dystrophy with the potential of rapidly distinguishing promising therapeutic drugs from those unlikely to be ...

Study examines disruption of circadian rhythm as risk factor for diseases

December 11, 2018
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.

Researchers explore new way of killing malaria in the liver

December 8, 2018
In the ongoing hunt for more effective weapons against malaria, international researchers said Thursday they are exploring a pathway that has until now been little studied—killing parasites in the liver, before the illness ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.